NOVO NORDISK RECRUITING STUDIES: • EX6018-4758 (ZEUS) – Cardiovascular risk/CKD/Inflammation This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation. The study’s duration will last up to 4 [...]
We are a specialized clinical research company that conducts trials on behalf of our partners in the fields of endocrinology, diabetes, cardiovascular disease, renal disease, and beyond.
PlanIt Research is affiliated with the Endocrine Center of Houston.
CONTACT INFORMATION
10837 Katy Frwy, #200
Houston, TX 77079
713-973-3418
713-973-3415
info@PlanItResearch.com
© Copyright 2023 PlanIt Research | All Rights Reserved